Note: Ingredients listed on restricted chemical lists
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
N/A
General Information
Revision date
2021-06-25
Product name
HDL CHOLESTEROL DIRECT_R1
Product name
HDL CHOLESTEROL DIRECT_R1
Identification on the label/Trade name
Erba Lachema s.r.o
CAS No.
55965-84-9
1.2.1 Relevant identified uses
Diagnostic reagent for quantitative in vitro determination of HDL Cholesterol in human serum and plasma
Manufacturer Name
Erba Lachema s.r.o
Icons in SDS
Company Information
company name
Erba Lachema s.r.o
e-mail address of the competent person responsible for the Safety Data Sheet
msds@erbamannheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Classification of the mixture in accordance with Regulation (EC) No 1272/2008 The mixture is classified as dangerous. Skin Sens. 1A, H317 Full text of all classifications and hazard statements is given in the section 16. Most serious adverse effects on human health and the environment May cause an allergic skin reaction.
Signal word
Warning 3.0
Hazardous Ingredients
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-2H-isothiazol-3-one
Hazard statements
H317 May cause an allergic skin reaction.
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower. P333+P313 If skin irritation or rash occurs: Get medical advice/attention.
2.3 Other hazards
The mixture does not contain substances with endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605. Mixture does not contain any substance meet the criteria for PBT or vPvB in accordance with Annex XIII of Regulation (EC) No. 1907/2006 (REACH) as amended.
